B Cell Receptor Cross-Linking Prevents Fas-Induced Cell Death by Inactivating the IL-1β-Converting Enzyme Protease and Regulating Bcl-2/Bcl-x Expression

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3168-3177

  Brás, Alexandra ^a   Martinez A , Carlos ^a   Baixeras, Elena ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2L1 PROTEIN, MOUSE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; FAS ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; LYMPHOCYTE ANTIGEN RECEPTOR; N ACETYL TYROSYL VALYL ALANYL ASPARTYL CHLOROMETHYL KETONE; N-ACETYL-TYROSYL-VALYL-ALANYL-ASPARTYL CHLOROMETHYL KETONE; PEPTIDE CHLOROMETHYL KETONE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; PROTEIN BCL X;

ANIMAL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BIOSYNTHESIS; CELL CULTURE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME SPECIFICITY; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; CASPASE 1; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DOWN-REGULATION; ENZYME ACTIVATION; IMMUNOGLOBULIN G; INTERLEUKIN-1; LYMPHOMA, B-CELL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, B-CELL; SUBSTRATE SPECIFICITY; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0031255312     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Smith, C. A., G. Williams, R. Kingston, E. J. Jenkinson, and J. J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic culture. Nature 337:181.
2. Tsubata, T., J. Wu, and T. Honjo. 1993. B cell apoptosis induced by antigen receptor crosslinking is blocked by a T cell signal through CD40. Nature 364: 645.
3. Valentine, M. A., and K. A. Licciardi. 1992. Rescue from anti-IgM induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur. J. Immunol. 22:3141.
4. Genaro, A. M., J. A. Gonzalo. L Boscá, and C. Martinez-A. 1994. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression. Eur. J. Immunol. 24:2515.
5. Baixeras, E., M. C. Moreno, and C. Martinez-A. 1996. CD2 ligation abrogates antigen independent-apoptosis in B cells. Cell. Immunol. 171:55.
6. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Möller, W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
7. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
8. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
9. Baixeras, E., L. Boscá, C. Stauber, A. Gonzalez, A. C. Carrera, J. A. Gonzalo, and C. Martinez-A. 1994. From apoptosis to autoimmunity: insights from the signaling pathways leading to proliferation or to programmed cell death. Immunol. Rev. 142:53.
10. Singer, G. G., A. C. Carrera, A. Marshak-Rothstein, C. Martinez-A., and A. K. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6:913.
11. Chinnaiyan, A. M., K. O'Rouke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with death domain of Fas and initiates apoptosis. Cell 81:505.
12. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein sequence that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795.
13. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817.
14. Mandik, L., K.-A. T. Nguyen, and J. Erikson. 1995. Fas receptor expression on B-lineage cells. Eur. J. Immunol. 25:3148.
15. Onel, K. B., C. L. Tucek-Szabo, D. Ashany, E. Lacy, J. Nikolic-Zugic, and K. B. Elkon. 1995. Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny. Eur. J. Immunol. 25:2940.
16. Rothstein, T. L., J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
17. Garrone, P., E. M. Neidhardt, E. Garcia, L. Galibert, C. van-Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265.
18. Schattner, E. J., K. B. Elkon, D. H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1FAs pathway. J. Exp. Med. 182:1557.
19. Foote, L. C., R. H. Howard, A. M. Rothstein, and T. L. Rothstein. 1996. IL-4 induces Fas resistance in B cells. J. Immunol. 157:2749.
20. Baixeras, E., G. Kroemer, E. Cuende, C. Márquez, L. Bosca, J. E. Alés, and C. Martinez-A. 1993. Signal transduction pathways involved in B cell induction. Immunol. Rev. 132:5.
21. Foote, L. C., T. J. Schneider, G. M. Fisher, J. K. M. Wang, B. Rasmussen, K. A. Campbell, D. H. Lynch, S. Ju, A. Marshak-Rothstein, and T. Rothstein. 1996. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J. Immunol. 157:1878.
22. Lanier, L. L., N. L. Warner, J. A. Ledbetter, and L. A. Herzenberg. 1981. Quantitative immunofluorescent analysis of surface phenotype of murine B cell lymphomas and plasmacytomas with monoclonal antibodies. J. Immunol. 127:1691.
23. Sadoul, R., P. A. Fernandez, A. Quiquerez, I. Martinou, M. Maki, M. Schröter, D. J. Becherer, M. Irmel, C. Tschopp, and J. C. Martinou. 1996. Involvement of the proteosome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15:3845.
24. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakanes, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771.
25. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like prolease in Fas-mediated apoptosis. Nature 375:78.
26. Carrera, A. C., P. Li, and T. M. Roberts. 1991. Characterization of an active, non-myristylated, cytoplasmic form on the lymphoid protein tyrosine kinase pp561ck. Int. Immunol. 3:673.
27. Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723.
28. Gill-B., M., H. Nishikata, G. Chan, T. L. Delovitch, and A. Ochi. 1994. Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes. Immunol. Rev. 142:113.
29. Gulbins, E., R. Bissonette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, F. Lang, R. Kolesnick, A. Altman, and D. Green. 1995. Fas-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341.
30. Los, M., M. Van de Craen, L. C. Penning, H. Schenk, M. Westendorp, P. A. Baeuerle., W. Dröge, P. H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375:81.
31. Walker, N. P. C., R. V. Talanian, K. D. Brady, L. C. Dang, N. J. Bump, C. R. Ferenz, S. Franklin, T. Ghayur, M. C. Hackett, D. L. Hammill, L. Herzog, M. Hugunin, W. Houy, J. A. Mankovich, L. McGuiness, E. Orlewicz, M. Pakind, C. A. Pratt, P. Reis, A. Summani, M. Terranova, J. P. Welch, L. Xiong, A. Möller, D. E. Tracy, R. Kamen, and W. W. Wong. 1994. Crystal structure of the cysteine protease interleukin-1β-converting enzyme:A(p20/p10)2 homodimer. Cell 78:343.
32. Rothstein, T. L., T. R. Baeker, R. A. Miller, and D. L. Kolber. 1986. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester. Cell. Immunol. 102:364.
33. Tewari, M., L. T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirer, G. S. Salvesen, and V. M. Dixit. 1995. Yama/CPP32-β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801.
34. Emoto, Y., Y. Manome, G. Meinhardt, H. Kisaki, S. Kharbanda, M. Robertson, T. Ghayur, W. W. Wong, R. Kamen, R. Weichselbaum, and D. Kufe. 1995. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J. 14:6148.
35. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607.
36. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of Bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621.
37. 2 in breast carcinoma cells. Oncogene 10:2297.
38. Mandal, M., S. B. Maggirwar, N. Sharma, S. H. Kaufmann, S. Sun, and R. Kumar. 1996. Bcl-2 prevents CD95 (Fas/APO)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-κB signaling pathway. J. Biol. Chem. 271:30354.
39. Chinnaiyan, A. M., K. Orth, K. O'Rourke, H. Duan, G. G. Poirier, and V. M. Dixit. 1996. Molecular ordering the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271: 4573.
40. Memon, S. A., M. B. Moreno, D. Petrak, and C. M. Zacharchuck. 1995. Bcl-2 blocks glucocorticoid- but not Fas-or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644.
41. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed. 1995. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279.
42. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609.
43. Sato, T., M. Hanada, S. Bodrug, S. Irie, N. Iwama, L. H. Boise, C. B. Thompson, E. Golemis, L. Fong, H.-G. Wang, and J. C. Reed. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238.
44. Ghayur, T., M. Hugunin, R. V. Valanian, S. Ratnofsky, C. Quinlan, Y. Emoto, P. Pandey, R. Datta, Y. Huang, S. Kharbanda, H. Allen, R. Kamen, W. Wong, and D. Kufe. 1996. Proteolytic activation of protein kinase δ by ICE/CED3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:2399.
45. Berra, E., M. T. Diaz-Meco, I. Dominguez, M. M. Municio, L. Sanz, J. Lozano, R. S. Chapkin, and J. Moscat. 1993. Protein kinase ζ isoform is critical for mitogenic signal transduction. Cell 74:555.
46. Diaz-Meco, M. T., M. M. Minicio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz, and J. Moscat. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86:777.
47. Enari, M., A. Hase, and S. Nagata. 1995. Apoptosis by cytosolic extract from Fas-activated cells. EMBO J. 14:5201.
48. Shimizu, S., Y. Eguchi, W. Kamiike, H. Matsuda, and Y. Tsujimoto. 1996. Bcl-2 expression prevents activation of ICE protease cascade. Oncogene 12:2251.
49. Grillot, D. A. M., R. Merino, J. C. Pena, W. C. Fanslow, F. D. Finkelman, C. B. Thompson, and G. Nuñez. 1996. Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:381.
50. Hasbold, J., C. Johnson-Leger, C. J. Atkins, E. A. Clark, and G. G. B. Klaus. 1994. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24:1835.